Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,491 across all filing types
Latest filing 2026-05-20 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “2025年年度股东会决议公告” and provides detailed vote counts and percentages for each resolution considered at the 2025 annual general meeting. It does not contain the full annual report or financial statements but instead publishes the official voting results on several AGM proposals. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (Code: DVA).
2026-05-20 Chinese
关于天康生物股份有限公司2025年年度股东会之法律意见书
Regulatory Filings Classification · 92% confidence The document is a legal opinion letter (“法律意见书”) prepared by a law firm regarding the legality of convening and conducting TianKang Bio’s 2025 Annual General Meeting, including procedures, attendee qualifications, and vote tallies. It does not itself constitute AGM materials (presentations, minutes) nor is it a standalone financial report. Instead, it is a compliance/attestation document by external counsel, fitting the “Regulatory Filings (RNS)” category for general regulatory announcements and legal certifications.
2026-05-20 Chinese
关于控股子公司公开发行股票并在北交所上市进展暨风险提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Tian Kang Bio Co., Ltd. regarding the progress and risk warning related to its controlling subsidiary's planned public issuance of shares and listing on the Beijing Stock Exchange. It details dates of board meetings, approvals, regulatory filings, and the current status of the listing application, including suspension and withdrawal of the sponsorship application. The document is an official announcement about the progress and risks of a capital market transaction, specifically a public offering and listing process. It does not contain financial statements or detailed financial data, nor is it a full report or transcript. It is not a report publication announcement since it contains substantive information about the progress and risks. This fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2026-05-08 Chinese
2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2026 first extraordinary general meeting (临时股东会) of Tian Kang Bio Co., Ltd. It includes information about the meeting date, attendance, voting results for board member elections, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or report content, but rather the official voting results and decisions made at the shareholders meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2372 characters, which is consistent with a voting results announcement rather than a full report or presentation. Therefore, the correct classification is DVA with high confidence.
2026-02-26 Chinese
关于董事会完成换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the completion of the board of directors' re-election and changes in board composition. It details the new board members, their roles, and the departure of a previous director. There is no financial data, no mention of annual or quarterly reports, and no indication of a meeting presentation or voting results. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2026-02-26 Chinese
2026年第一次临时股东会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, voting procedures, and results of a company's 2026 first extraordinary shareholders meeting. It details the legality and validity of the meeting process and the election of board members. The document is not a report of financial results, audit, or management discussion, but a legal opinion on the shareholders meeting. It is not an announcement of voting results per se, but a legal opinion on the meeting's legality and voting process. Given the content and purpose, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to the official voting results and their legal validation at a shareholders meeting.
2026-02-26 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.